List of works - Sufi M. Thomas

Abrogation of head and neck squamous cell carcinoma growth by epidermal growth factor receptor ligand fused to pseudomonas exotoxin transforming growth factor alpha-PE38

scientific article published on 01 October 2004

Antitumor effects of EGFR antisense guanidine-based peptide nucleic acids in cancer models

scientific article

Antitumor mechanisms of combined gastrin-releasing peptide receptor and epidermal growth factor receptor targeting in head and neck cancer.

scientific article published on April 2007

Antitumor mechanisms of systemically administered epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck

scientific article published on 19 November 2007

Antitumor mechanisms of targeting the PDK1 pathway in head and neck cancer

scientific article

Autophagy-dependent secretion: mechanism, factors secreted, and disease implications

scientific article published on 14 April 2019

Carfilzomib and ONX 0912 inhibit cell survival and tumor growth of head and neck cancer and their activities are enhanced by suppression of Mcl-1 or autophagy

scientific article published on 28 August 2012

Chemokine receptor 7 activates phosphoinositide-3 kinase-mediated invasive and prosurvival pathways in head and neck cancer cells independent of EGFR.

scientific article published on September 2005

Chemoprevention of head and neck cancer by simultaneous blocking of epidermal growth factor receptor and cyclooxygenase-2 signaling pathways: preclinical and clinical studies.

scientific article published on 19 February 2013

Collagen type XI α1 facilitates head and neck squamous cell cancer growth and invasion

scientific article

Combined inhibition of PLC{gamma}-1 and c-Src abrogates epidermal growth factor receptor-mediated head and neck squamous cell carcinoma invasion

scientific article

Combined inhibition of c-Src and epidermal growth factor receptor abrogates growth and invasion of head and neck squamous cell carcinoma

scientific article

Correction

Cross-talk between G protein-coupled receptor and epidermal growth factor receptor signaling pathways contributes to growth and invasion of head and neck squamous cell carcinoma

scientific article published on 15 December 2006

Cucurbitacin B and I inhibits colon cancer growth by targeting the Notch signaling pathway

scientific article published on 28 January 2020

Enhancement of head and neck squamous cell carcinoma proliferation, invasion, and metastasis by tumor-associated fibroblasts in preclinical models

scientific article published on June 2013

Epidermal growth factor receptor expression and gene copy number in the risk of oral cancer

scientific article

Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation

scientific article published on 12 July 2010

Erlotinib, erlotinib-sulindac versus placebo: a randomized, double-blind, placebo-controlled window trial in operable head and neck cancer.

scientific article

Establishment of a human squamous cell carcinoma cell line of the upper aero-digestive tract.

scientific article published on September 1997

Expression of EGFR, VEGF, and NOTCH1 suggest differences in tumor angiogenesis in HPV-positive and HPV-negative head and neck squamous cell carcinoma

scientific article published on 04 May 2013

First-in-human trial of a STAT3 decoy oligonucleotide in head and neck tumors: implications for cancer therapy.

scientific article published on 20 June 2012

Gefitinib potentiates myeloid cell differentiation by ATRA

scientific article published on 28 February 2008

Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3

scientific article published on 16 September 2009

HGF and c-Met participate in paracrine tumorigenic pathways in head and neck squamous cell cancer

scientific article

Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors

scientific article

Human rhomboid family-1 gene RHBDF1 participates in GPCR-mediated transactivation of EGFR growth signals in head and neck squamous cancer cells

scientific article

Inhibition of EGFR-STAT3 signaling with erlotinib prevents carcinogenesis in a chemically-induced mouse model of oral squamous cell carcinoma.

scientific article

Intratumoral epidermal growth factor receptor antisense DNA therapy in head and neck cancer: first human application and potential antitumor mechanisms

scientific article published on 09 February 2009

Lack of toxicity of a STAT3 decoy oligonucleotide.

scientific article

Metastatic Tumor-in-a-Dish, a Novel Multicellular Organoid to Study Lung Colonization and Predict Therapeutic Response

scientific article published on 23 January 2019

Mitogenic effects of gastrin-releasing peptide in head and neck squamous cancer cells are mediated by activation of the epidermal growth factor receptor

scientific article

Molecular communication between tumor-associated fibroblasts and head and neck squamous cell carcinoma ⬇️

scientific article published on January 26, 2013

Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting

scientific article published on September 2006

Occupational exposure of oropharyngeal human papillomavirus amongst otolaryngologists

scientific article published on 11 November 2019

PUMA mediates EGFR tyrosine kinase inhibitor-induced apoptosis in head and neck cancer cells

scientific article

Perineural growth in head and neck squamous cell carcinoma: a review

scientific article

Pharmacokinetic and pharmacodynamic properties of EGFR inhibitors under clinical investigation.

scientific article published on May 2004

Phase 1 study of EGFR-antisense DNA, cetuximab, and radiotherapy in head and neck cancer with preclinical correlatives

scientific article published on 06 October 2018

Phosphorylation of TNF-alpha converting enzyme by gastrin-releasing peptide induces amphiregulin release and EGF receptor activation.

scholarly article

Pleotropic role of RNA binding protein CELF2 in autophagy induction

scientific article published on 24 April 2019

Potent Antitumor Effects of a Combination of Three Nutraceutical Compounds

scientific article published in Scientific Reports

Radiation-induced fibrosis: mechanisms and implications for therapy

scientific article

SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells

scientific article published on September 2004

Selective inhibition of ADAM metalloproteases as a novel approach for modulating ErbB pathways in cancer

scientific article published in March 2007

Serum biomarker modulation following molecular targeting of epidermal growth factor and cyclooxygenase pathways: a pilot randomized trial in head and neck cancer.

scientific article

Serum biomarkers as potential predictors of antitumor activity of cetuximab-containing therapy for locally advanced head and neck cancer

scientific article

Targeting GPCR-mediated p70S6K activity may improve head and neck cancer response to cetuximab

scientific article published on 8 June 2011

Targeting Stat3 abrogates EGFR inhibitor resistance in cancer.

scientific article

Targeting TORC1/2 enhances sensitivity to EGFR inhibitors in head and neck cancer preclinical models.

scientific article

Targeting mesenchymal exaptation to mitigate tumor growth

scientific article published on 15 August 2011

Targeting the vasopressin type-2 receptor for renal cell carcinoma therapy

scientific article published on 15 October 2019

The next generation proteasome inhibitors carfilzomib and oprozomib activate prosurvival autophagy via induction of the unfolded protein response and ATF4.

scientific article

The role of the innate and adaptive immune response in HPV-associated oropharyngeal squamous cell carcinoma

scientific article published on 12 August 2019

Tissue distribution of liposome-mediated epidermal growth factor receptor antisense gene therapy

scientific article published in July 2003

Tumor matrix protein collagen XIα1 in cancer

scientific article

List of works by Sufi M. Thomas

Abrogation of head and neck squamous cell carcinoma growth by epidermal growth factor receptor ligand fused to pseudomonas exotoxin transforming growth factor alpha-PE38

Antitumor effects of EGFR antisense guanidine-based peptide nucleic acids in cancer models

Antitumor mechanisms of combined gastrin-releasing peptide receptor and epidermal growth factor receptor targeting in head and neck cancer.

Antitumor mechanisms of systemically administered epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck

Antitumor mechanisms of targeting the PDK1 pathway in head and neck cancer

Autophagy-dependent secretion: mechanism, factors secreted, and disease implications

Carfilzomib and ONX 0912 inhibit cell survival and tumor growth of head and neck cancer and their activities are enhanced by suppression of Mcl-1 or autophagy

Chemokine receptor 7 activates phosphoinositide-3 kinase-mediated invasive and prosurvival pathways in head and neck cancer cells independent of EGFR.

Chemoprevention of head and neck cancer by simultaneous blocking of epidermal growth factor receptor and cyclooxygenase-2 signaling pathways: preclinical and clinical studies.

Collagen type XI α1 facilitates head and neck squamous cell cancer growth and invasion

Combined inhibition of PLC{gamma}-1 and c-Src abrogates epidermal growth factor receptor-mediated head and neck squamous cell carcinoma invasion

Combined inhibition of c-Src and epidermal growth factor receptor abrogates growth and invasion of head and neck squamous cell carcinoma

Correction

Cross-talk between G protein-coupled receptor and epidermal growth factor receptor signaling pathways contributes to growth and invasion of head and neck squamous cell carcinoma

Cucurbitacin B and I inhibits colon cancer growth by targeting the Notch signaling pathway

Enhancement of head and neck squamous cell carcinoma proliferation, invasion, and metastasis by tumor-associated fibroblasts in preclinical models

Epidermal growth factor receptor expression and gene copy number in the risk of oral cancer

Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation

Erlotinib, erlotinib-sulindac versus placebo: a randomized, double-blind, placebo-controlled window trial in operable head and neck cancer.

Establishment of a human squamous cell carcinoma cell line of the upper aero-digestive tract.

Expression of EGFR, VEGF, and NOTCH1 suggest differences in tumor angiogenesis in HPV-positive and HPV-negative head and neck squamous cell carcinoma

First-in-human trial of a STAT3 decoy oligonucleotide in head and neck tumors: implications for cancer therapy.

Gefitinib potentiates myeloid cell differentiation by ATRA

Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3

HGF and c-Met participate in paracrine tumorigenic pathways in head and neck squamous cell cancer

Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors

Human rhomboid family-1 gene RHBDF1 participates in GPCR-mediated transactivation of EGFR growth signals in head and neck squamous cancer cells

Inhibition of EGFR-STAT3 signaling with erlotinib prevents carcinogenesis in a chemically-induced mouse model of oral squamous cell carcinoma.

Intratumoral epidermal growth factor receptor antisense DNA therapy in head and neck cancer: first human application and potential antitumor mechanisms

Lack of toxicity of a STAT3 decoy oligonucleotide.

Metastatic Tumor-in-a-Dish, a Novel Multicellular Organoid to Study Lung Colonization and Predict Therapeutic Response

Mitogenic effects of gastrin-releasing peptide in head and neck squamous cancer cells are mediated by activation of the epidermal growth factor receptor

Molecular communication between tumor-associated fibroblasts and head and neck squamous cell carcinoma ⬇️

Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting

Occupational exposure of oropharyngeal human papillomavirus amongst otolaryngologists

PUMA mediates EGFR tyrosine kinase inhibitor-induced apoptosis in head and neck cancer cells

Perineural growth in head and neck squamous cell carcinoma: a review

Pharmacokinetic and pharmacodynamic properties of EGFR inhibitors under clinical investigation.

Phase 1 study of EGFR-antisense DNA, cetuximab, and radiotherapy in head and neck cancer with preclinical correlatives

Phosphorylation of TNF-alpha converting enzyme by gastrin-releasing peptide induces amphiregulin release and EGF receptor activation.

Pleotropic role of RNA binding protein CELF2 in autophagy induction

Potent Antitumor Effects of a Combination of Three Nutraceutical Compounds

Radiation-induced fibrosis: mechanisms and implications for therapy

SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells

Selective inhibition of ADAM metalloproteases as a novel approach for modulating ErbB pathways in cancer

Serum biomarker modulation following molecular targeting of epidermal growth factor and cyclooxygenase pathways: a pilot randomized trial in head and neck cancer.

Serum biomarkers as potential predictors of antitumor activity of cetuximab-containing therapy for locally advanced head and neck cancer

Targeting GPCR-mediated p70S6K activity may improve head and neck cancer response to cetuximab

Targeting Stat3 abrogates EGFR inhibitor resistance in cancer.

Targeting TORC1/2 enhances sensitivity to EGFR inhibitors in head and neck cancer preclinical models.

Targeting mesenchymal exaptation to mitigate tumor growth

Targeting the vasopressin type-2 receptor for renal cell carcinoma therapy

The next generation proteasome inhibitors carfilzomib and oprozomib activate prosurvival autophagy via induction of the unfolded protein response and ATF4.

The role of the innate and adaptive immune response in HPV-associated oropharyngeal squamous cell carcinoma

Tissue distribution of liposome-mediated epidermal growth factor receptor antisense gene therapy

Tumor matrix protein collagen XIα1 in cancer